Objective To determine the frequency, characteristics, and outcomes of cerebrovascular
events (Cer VE s), as well as clinical and autoantibody associations in a multiethnic/racial …

Objective To determine stroke prevalence, mechanisms, and long-term outcome in a cohort
of Hispanic patients with systemic lupus erythematosus (SLE). Methods We analyzed …

Objectives: To study the annual incidence and standardized incidence ratio (SIR) of
cerebrovascular accident (CVA) in patients with systemic lupus erythematosus (SLE) …

Objective To study the occurrence of ischaemic and haemorrhagic stroke in systemic lupus
erythematosus (SLE) compared with the general population by age, sex and time since SLE …

Stroke is a major cause of morbidity, mortality and disability in systemic lupus erythematosus
(SLE). Patients with SLE have a two-fold increase in the risk of stroke with younger patients …

Previous studies of stroke in systemic lupus erythematosus (SLE) have had limited statistical
power, combined stroke subtypes into composite outcomes, and lacked a reference …

Objective Cardiovascular disease (CVD) has been recognized as a major cause of morbidity
in patients with systemic lupus erythematosus (SLE), but it is not clear whether increased …

Objective. The incidence of thrombosis in patients with systemic lupus erythematosus (SLE)
is 25 to 50-fold higher than in the general population; we aimed to define the characteristics …

Despite improved prognosis, patients with systemic lupus erythematosus (SLE) remain at
increased risk for early death. Vascular events (VE) occur with increased frequency and …

Objectives Patients with RA and SLE have an excess cardiovascular risk. We aimed to
evaluate outcomes of acute cardiovascular events in these patients. Methods Using a …